ARIH2
From Wikipedia, the free encyclopedia
Ariadne homolog 2 (Drosophila)
|
||||||||||||||
Identifiers | ||||||||||||||
Symbol(s) | ARIH2; ARI2; FLJ10938; FLJ33921; TRIAD1 | |||||||||||||
External IDs | OMIM: 605615 MGI: 1344361 HomoloGene: 48424 | |||||||||||||
|
||||||||||||||
Orthologs | ||||||||||||||
Human | Mouse | |||||||||||||
Entrez | 10425 | 23807 | ||||||||||||
Ensembl | ENSG00000177479 | ENSMUSG00000064145 | ||||||||||||
Uniprot | O95376 | Q3TK92 | ||||||||||||
Refseq | NM_006321 (mRNA) NP_006312 (protein) |
NM_011790 (mRNA) NP_035920 (protein) |
||||||||||||
Location | Chr 3: 48.93 - 49 Mb | Chr 9: 108.46 - 108.51 Mb | ||||||||||||
Pubmed search | [1] | [2] |
Ariadne homolog 2 (Drosophila), also known as ARIH2, is a human gene.[1]
[edit] References
[edit] Further reading
- Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.". Gene 138 (1-2): 171–4. PMID 8125298.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library.". Gene 200 (1-2): 149–56. PMID 9373149.
- van der Reijden BA, Erpelinck-Verschueren CA, Löwenberg B, Jansen JH (1999). "TRIADs: a new class of proteins with a novel cysteine-rich signature.". Protein Sci. 8 (7): 1557–61. PMID 10422847.
- Aguilera M, Oliveros M, Martínez-Padrón M, et al. (2000). "Ariadne-1: a vital Drosophila gene is required in development and defines a new conserved family of ring-finger proteins.". Genetics 155 (3): 1231–44. PMID 10880484.
- Hu RM, Han ZG, Song HD, et al. (2000). "Gene expression profiling in the human hypothalamus-pituitary-adrenal axis and full-length cDNA cloning.". Proc. Natl. Acad. Sci. U.S.A. 97 (17): 9543–8. doi: . PMID 10931946.
- Wong ES, Fong CW, Lim J, et al. (2002). "Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling.". EMBO J. 21 (18): 4796–808. PMID 12234920.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi: . PMID 12477932.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40–5. doi: . PMID 14702039.
- Brandenberger R, Wei H, Zhang S, et al. (2005). "Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.". Nat. Biotechnol. 22 (6): 707–16. doi: . PMID 15146197.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi: . PMID 15489334.
- Marteijn JA, van Emst L, Erpelinck-Verschueren CA, et al. (2006). "The E3 ubiquitin-protein ligase Triad1 inhibits clonogenic growth of primary myeloid progenitor cells.". Blood 106 (13): 4114–23. doi: . PMID 16118314.
- Stelzl U, Worm U, Lalowski M, et al. (2005). "A human protein-protein interaction network: a resource for annotating the proteome.". Cell 122 (6): 957–68. doi: . PMID 16169070.
- Rual JF, Venkatesan K, Hao T, et al. (2005). "Towards a proteome-scale map of the human protein-protein interaction network.". Nature 437 (7062): 1173–8. doi: . PMID 16189514.
- Marteijn JA, van der Meer LT, van Emst L, et al. (2007). "Gfi1 ubiquitination and proteasomal degradation is inhibited by the ubiquitin ligase Triad1.". Blood 110 (9): 3128–35. doi: . PMID 17646546.